Metformin × pharmacokinetics & dosing

SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2023

Do oral antidiabetic medications alter the risk of Parkinson's disease? An updated systematic review and meta-analysis.

Yanna Xie et al.PubMed ↗Publisher ↗

What the trial testedas reported · 2023

Range includes no effect

No clear effect on pharmacokinetics & dosing

+5%−9% to +22%

Bigger than 1 in 10 on the map

As reported

HR 1.05, 95% CI 0.91–1.22

One number in the abstract

the abstract, start to end

risk of PD among users of metformin (HR: 1.05 95% CI: 0.91, 1.22 I

← favours treatmentfavours comparator →
could be chance
Pharmacokinetics & dosing
HR 1.050.91–1.22
MetforminPharmacokinetics & dosing
1 / 3

8 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37500992